# Title

 Food and Drugs. PART 206â€”IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE


# ID

 CFR-2018-title21-vol4.Pt. 206


# Structured Analysis Summary

| Type        | Values                                                                                                             |
|:------------|:-------------------------------------------------------------------------------------------------------------------|
| Constraints | ['after']                                                                                                          |
| Duration    | ['1.0 year']                                                                                                       |
| Condition   | ['not subject to', 'subject to', 'if', 'unless']                                                                   |
| Entities    | ['Scope', 'Beltsville, MD', 'Homeopathic', 'G112', 'Solid', 'Food', 'Rm', 'Exemption', 'Code', 'Drug', 'Research'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                    |
|:--------------|:-------------------------------------------------------------------------------------------|
| after         | that is cut into the dosage form surface after  it has been completed.                     |
| after         | of the approved application will have 1 year after the date of an agency denial to imprint |


## Duration

| Duration   | Context                                                                                                                                            |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------|
| 1.0 year   | If FDA denies the request, the holder of the approved application will have 1 year after the date of an agency denial to imprint the drug product. |


## Condition

| Condition      | Context                                                                                                                 |
|:---------------|:------------------------------------------------------------------------------------------------------------------------|
| unless         | products, biological drug products, and homeopathic drug products, unless  otherwise exempted under &#167;&#8201;206.7. |
|                |                   Definitions.                                                                                          |
| if             | are exempt from the requirements of this part if they are designed to copy the active drug                              |
| subject to     | or unique physical characteristics: (1) For a drug subject to premarket approval, FDA may provide an exemption from     |
| not subject to | (2) Any product  not subject to premarket approval is exempt from the requirement of                                    |
| if             | approval is exempt from the requirement of &#167;&#8201;206.10 if , based on the product's size, shape, texture,        |
| unless         | introduced or delivered for introduction into interstate commerce unless it is clearly marked or imprinted with a       |
| unless         | introduced or delivered for introduction into interstate commerce unless it is clearly marked or imprinted with a       |
| subject to     | the review is complete, the drug product is subject to  the requirements of the rule.                                   |


## Entities

| Entities       | Context                                                                                                                           |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------|
| Food           | Food  and Drugs.                                                                                                                  |
| Scope          | Scope .                                                                                                                           |
| Drug           | Drug product means a finished dosage form, e.g., a                                                                                |
| Solid          | Solid oral dosage form means capsules, tablets, or similar                                                                        |
| Research       | division in the Center for Drug Evaluation and Research (CDER), Food and Drug Administration, 5901-B Ammendale Rd.,               |
| Beltsville, MD | (CDER), Food and Drug Administration, 5901-B Ammendale Rd., Beltsville, MD 20705-1266 or the Food and Drug Administration, Center |
| Research       | division in the Center for Drug Evaluation and Research (CDER), Food and Drug Administration, 5901-B Ammendale Rd.,               |
| Rm             | 71,  Rm .                                                                                                                         |
| G112           | G112 , Silver Spring, MD 20993-0002.                                                                                              |
| Exemption      | Exemption requests should be submitted in writing to the                                                                          |
| Code           | Code  imprint required.                                                                                                           |
| Homeopathic    | Homeopathic drug products are required only to bear an                                                                            |


